Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Higgins

Showing results (81-90 of 283) with videos related to

Pageof 29
Sort By:
Gut|May 13, 2005
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitisP D R Higgins, M Schwartz, J Mapili, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2008
The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitisE J Irvine, C-H Yeh, D Ramsey, et al.
Journal of Crohn'S & Colitis|August 14, 2013
Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?Akbar K Waljee, Ryan W Stidham, Peter D R Higgins, et al.
Crohn'S & Colitis 360|February 13, 2023
Preferences of Adult Patients With Inflammatory Bowel Disease for Attributes of Clinical Trials: Evidence From a Choice-Based Conjoint AnalysisDallas Wood, Katherine Kosa, Derek Brown, et al.
Experimental and Molecular Pathology|April 2, 2015
Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugsEva S Rodansky, Laura A Johnson, Sha Huang, et al.
Inflammatory Bowel Diseases|May 29, 2015
Impact of Quality Improvement Educational Interventions on Documented Adherence to Quality Measures for Adults with Crohn's DiseaseLaurence Greene, Tamar Sapir, Kathleen Moreo, et al.
Nature Reviews. Cancer|December 13, 2005
Statins and cancer preventionMarie-France Demierre, Peter D R Higgins, Stephen B Gruber, et al.
Alimentary Pharmacology & Therapeutics|October 24, 2008
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins, D T Rubin, K Kaulback, et al.
Digestive Diseases and Sciences|February 14, 2016
Continuing Medical Education Improves Gastroenterologists' Compliance with Inflammatory Bowel Disease Quality MeasuresTamar Sapir, Kathleen Moreo, Jeffrey D Carter, et al.
Gastroenterology|October 23, 2020
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor ColitisShrinivas Bishu, Joanna Melia, William Sharfman, et al.
Pageof 29

Showing results (81-90 of 283) with videos related to

Sort By:
Pageof 29
Gut|May 13, 2005
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitisP D R Higgins, M Schwartz, J Mapili, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2008
The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitisE J Irvine, C-H Yeh, D Ramsey, et al.
Journal of Crohn'S & Colitis|August 14, 2013
Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?Akbar K Waljee, Ryan W Stidham, Peter D R Higgins, et al.
Crohn'S & Colitis 360|February 13, 2023
Preferences of Adult Patients With Inflammatory Bowel Disease for Attributes of Clinical Trials: Evidence From a Choice-Based Conjoint AnalysisDallas Wood, Katherine Kosa, Derek Brown, et al.
Experimental and Molecular Pathology|April 2, 2015
Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugsEva S Rodansky, Laura A Johnson, Sha Huang, et al.
Inflammatory Bowel Diseases|May 29, 2015
Impact of Quality Improvement Educational Interventions on Documented Adherence to Quality Measures for Adults with Crohn's DiseaseLaurence Greene, Tamar Sapir, Kathleen Moreo, et al.
Nature Reviews. Cancer|December 13, 2005
Statins and cancer preventionMarie-France Demierre, Peter D R Higgins, Stephen B Gruber, et al.
Alimentary Pharmacology & Therapeutics|October 24, 2008
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flaresP D R Higgins, D T Rubin, K Kaulback, et al.
Digestive Diseases and Sciences|February 14, 2016
Continuing Medical Education Improves Gastroenterologists' Compliance with Inflammatory Bowel Disease Quality MeasuresTamar Sapir, Kathleen Moreo, Jeffrey D Carter, et al.
Gastroenterology|October 23, 2020
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor ColitisShrinivas Bishu, Joanna Melia, William Sharfman, et al.
Pageof 29